Page last updated: 2024-10-19

phenylpyruvic acid and Nephrosis

phenylpyruvic acid has been researched along with Nephrosis in 1 studies

phenylpyruvic acid: RN given refers to parent cpd
phenylpyruvate : A 2-oxo monocarboxylic acid anion resulting from deprotonation of the carboxy group of either keto- or enol-phenylpyruvic acid.
keto-phenylpyruvic acid : A 2-oxo monocarboxylic acid that is 3-phenylpropanoic acid substituted by an oxo group at position 2. It is an intermediate metabolite in the phenylalanine pathway.

Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FRITZELL, S1
JAGENBURG, OR1
SCHNUERER, LB1

Other Studies

1 other study available for phenylpyruvic acid and Nephrosis

ArticleYear
FAMILIAL CIRRHOSIS OF THE LIVER, RENAL TUBULAR DEFECTS WITH RICKETS AND IMPAIRED TYROSINE METABOLISM.
    Acta paediatrica, 1964, Volume: 53

    Topics: Child; Chronic Kidney Disease-Mineral and Bone Disorder; Genetic Diseases, Inborn; Genetics; Humans;

1964